-
Pope Leo to hold giant mass for Angola's Catholics
-
From Armin van Buuren to Mochakk, electronic music dominates Coachella
-
Hollywood, Silicon Valley turn out for the 'Oscars of Science'
-
Australian soldier charged with war crimes vows to clear his name
-
Branded pop-up events take center stage at Coachella
-
AI 'agent' fever comes with lurking security threats
-
How France fell for reimagined 19th-century workers' canteens
-
South Korea's chainsaw artist carves a name for herself at 91
-
Blue Origin set to launch rocket with reusable booster for first time
-
Strait of Hormuz to stay closed until port blockade lifts, Iran says
-
Iraq fish die-off leaves farmers mourning lost livelihoods
-
Crisis-hit Bulgaria votes in eighth election in five years
-
'Pure joy' for Matarazzo after Copa del Rey triumph
-
Messi scores winner as Miami down Colorado on coach debut
-
Nuggets hold off T'Wolves, Cavs thump Raptors in NBA playoff openers
-
Fitzpatrick extends lead as Scheffler charges at RBC Heritage
-
Real Sociedad secure Copa del Rey penalty triumph over Atletico
-
'Scandalous' Marseille lose at Lorient, dent Champions League bid
-
Arteta urges Arsenal to have no regrets in Man City title showdown
-
Substitute Dupont helps Toulouse cruise past Castres in Top 14
-
Questions surround Warriors after NBA play-in exit
-
Man Utd beat Chelsea as Spurs stunned by Brighton equaliser
-
Cunha steers Man Utd towards Champions League at Chelsea's expense
-
Cavs cruise past Raptors in NBA playoff opener
-
England beat Iceland to stay perfect in Women's World Cup qualifying
-
Spurs 'not finished yet', says defiant De Zerbi
-
Germany's Gnabry a World Cup doubt after thigh injury
-
Spurs stunned by late Brighton equaliser, Leeds pull clear of trouble
-
Spurs count cost after Brighton draw leaves them in drop zone
-
'Scandalous' Marseille lose at Lorient, damage Champions League bid
-
Abhishek fireworks, Malinga spell sink Chennai
-
Napoli's Serie A title defence nears end with Lazio defeat
-
England run in 12 tries to hammer Scotland in Six Nations
-
Rybakina powers past Andreeva to reach Stuttgart final
-
At least 5 killed after gunman opens fire in Ukrainian capital
-
Bayern on cusp of title as Dortmund lose, Eta beaten on debut
-
Rublev, Fils fightbacks set up Barcelona Open final
-
Leeds pull clear of trouble, Bournemouth sink Newcastle
-
Spain rout Ukraine to boost Women's World Cup qualifying hopes
-
Bayern close in on Bundesliga title as Dortmund lose
-
Iran closes Hormuz Strait again, as Trump warns against 'blackmail'
-
US extends sanctions waiver on purchases of Russian oil
-
Trump signs order to fast-track research on psychedelic drugs
-
Cobolli downs Zverev to set up Munich final with Shelton
-
Pope arrives in Angola on Africa tour overshadowed by Trump
-
Thousands protest in Germany urging faster green shift
-
La Rochelle thump threadbare Bordeaux-Begles
-
Muchova battles past Svitolina to book Stuttgart final berth
-
Allegri rules out taking Italy job, wants to stay at AC Milan
-
Miller bludgeons Delhi to IPL win over Bengaluru
Biorasi Unveils New Website to Drive Sponsor Success with Biotech-Centric Strategies and Modular CRO Solutions
Relaunch puts customized CRO services front and center for today's Biotech and Biopharma innovators.
AVENTURA, FL / ACCESS Newswire / October 8, 2025 / Biorasi, a leading global full-service contract research organization (CRO), has relaunched its website to reflect a bold new direction: Empowering biotech sponsors with modular clinical trial solutions, AI-powered tools, and a renewed focus on sponsor-centric strategy.
"The future of clinical research belongs to those who can adapt, innovate, and deliver," said Chris O'Brien, CEO of Biorasi. "Our new website reflects a strategic evolution - one that puts biotech sponsors at the center of smarter, faster, and more flexible trials. It's a touchstone for the modular solutions and AI-powered tools that will define the next era of clinical success."
Key updates to the website include:
Focused Study Solutions: Critical standalone service offerings deliver the same high-performance features found in Biorasi's full-service strategies:
Study Rescue and Recovery Packages: Designed to salvage struggling clinical trials and restore timelines.
Flexible Data Sciences Solutions: Advanced analytics and biostatistics available as standalone services.
Specialized Services: Including Quality Assurance, Clinical Monitoring, and Safety & Pharmacovigilance, tailored to sponsor needs.
Accelerated Startup Modules: Fast-track solutions for trials requiring rapid market entry.
AI-Powered Feasibility: Dynamic clinical site modeling combined with targeted feasibility outreach and enrollment forecasting.
New Sponsor Strategy: A sharpened focus on the CRO competencies that matter most: Reliability, Flexibility, and Accessibility.
The redesigned website celebrates Biorasi's over two decades of industry leadership, clinical trial experience, and operational excellence:
Over 200 global studies executed.
Five FDA approvals in the past seven years.
$150M+ in recovered rescue studies.
6 weeks or less for database go-live.
Kickoff Meetings in 10 business days after LOI/WO.
60% repeat business from returning sponsors.
Studies conducted in 48 countries, reaching 65% of the global population.
About Biorasi
Biorasi is a global clinical research organization (CRO) that delivers speed-to-market strategies for small to midsized biotech and biopharma sponsors. With over two decades of expertise in running clinical trials across dermatology, oncology, neurology, nephrology, and other key therapeutic areas, Biorasi leverages reliable, flexible, and accessible solutions necessary to succeed in today's dynamic and evolving clinical trials industry. Contact Biorasi at [email protected] / (786) 388-0700.
SOURCE: Biorasi, LLC
View the original press release on ACCESS Newswire
A.O.Scott--AT